Presentations by Speaker
Catalogue of Presentations from NATF Educational Initiatives
Listing by Speaker
Joseph S. Alpert, MD
* The 10 Most Important Advances in Thrombosis Understanding During the Last 50 Years…with apologies to David Letterman: September 2008 Slides
Mary Amatangelo, RN, MS, APRN-BC, CCRN
* Prevention of Stroke: September 2008 Slides
Jack E. Ansell
* Point-of-Care INR Testing: March 2009 Slides
Elliot Marshall Antman, MD
* Acute Coronary Syndrome: September 2009
Summary
Slides
Video
Caitlin Augustine
* Patient Perspective: April 2009
Video
Steven Baroletti, PharmD, MBA
* Heparin-Induced Thrombocytopenia Education Programs: March 2008
Slides
* Heparin-Induced Thrombocytopenia: April 2009
Slides
Video
Kenneth A. Bauer, MD
* Hypercoagulability: April 2009
Slides
Video
* Post-Surgical Anticoagulation Management: Risk Management: Winter 2009
Slides
* Prevention and Treatment of Venous Thromboembolis: New Strategies and Guidelines for Improving Patient Outcomes: Winter 2009
Slides
Joshua A. Beckman, MD, MS
* Pre-Operative Evaluation of Patients with Vascular Disease: April 2009
Slides
Video
Deepak I. Bhatt, MD
* Coronary Artery Disease and Health Policy: September 2007
Slides
* Policies to Prevent and Minimize the Burden of CHD: September 2008
Slides
* What is the new Antiplatelet Therapy: September 2010
Slides
Summary
Brenda Blackburn
* Patient Perspective: April 2010
Summary
Video
Gideon Bosker, MD
* Education of Health Care Professionals: September 2007
Slides
Henri Bounameaux, MD
* Pulmonary Embolism 2009: July 2009
Summary
Slides
Video
Benjamin Brenner, MD
* Pregnancy and Thrombophillia: July 2009
Summary
Slides
Video
Julie F. Buring, ScD
* Prevention of Stroke and Heart Attack: September 2007
Slides
Enrico Cagliero, MD
* Diabetes and Thrombosis: September 2010
Slides
Summary
Charles A. Carter, PharmD, MBA
* Follow-On Bioloigcs: Legislative Background: April 2010
Summary
Slides
Video
Kelly Clark
* Patient Perspective: March 2008
Slides
Lawrence H. Cohn, MD
* Cardiac Surgery and Pulmonary Embolectomy: Janurary 2009
Slides
Video
Jon Corbino
* Patient Perspective: April 2010
Summary
Video
Mark A. Creager, MD
*Periphery Artery Disease Update: April 2009
Summary
Video
Gregory del Zoppo, MD
* Ischemic Stroke: September 2009
Summary
Slides
Video
* Stroke: September 2007
Slides
C. Gregory Elliott, MD
* Prevention of Venous Thromboembolism: September 2007
Slides
John Fanikos, RPh, MBA
* Bar-Coding Inpatient Medications to Improve Patient Safety: September 2008
Slides
* Hospital Pharmacists and DVT Prevention During Hospitalization at the Time of Hospital Discharge: a Patient Safety Issue: February 2007
Slides
* Novel Anticoagulants: March 2008
Slides
* Novel Anticoagulants: April 2009
Slides
Video
* New Thromboembolic Inhibitors: Fall 2009
Slides
Audio
* Panel Discussion: Drug Safety: April 2010
Video
* Patient Safety and Generic Biologics: Webinar: 2010
Slides
* Update on Heparin Contaminants and Quality Issues Surounding Unfractionated Heparin: July 2009
Slides
Video
Jawed Fareed, PhD
*Heparin Contaminants What are the Facts?: September 2010
Slides
Summary
* Drug Safety Considerations for Anticoagulants: April 2009
Slides
Video
* Generic versus Brand Name Anticoagulants: What Does the Future Hold?: April 2010
Summary
Slides
Video
* Generic vs. Brand Name Drugs : March 2008
Slides
* Oral Antithrombin and Anti Xa Agents and Their Impact in the Management of Thrombosis and Cardiovascular Disease: September 2009
* Substituting Generic Drugs for Brand Name Drugs: February 2007
Slides
* Unfractionated and LMWH: Safety and Regulatory Concerns: September 2008
Video
Karen Fiumara, PharmD
* Electronic Alerts to Prevent DVT: March 2008
Slides
* Electronic Alerts to Prevent DVT: April 2009
Slides
Video
* Human Alerts vs. Electronic Alerts: February 2007
Slides
* Prevention of Venous Thromboembolism: Can Computers Help?: September 2008
Slides
Brian F. Gage, MD, MSc
* Pharmacogenomics of Warfarin: Are the Promises Justified?: September 2008
Slides
Rear Admiral Steven K. Galson, MD, MPH (Acting Surgeon General of the United States)
* Call to Action to Prevent DVT and PE: Janurary 2009
Summary
Video
Bill Geerts, MD
* Controversies in the Peri-Operative Prevention of VTE: Winter 2009
Slides
Marie Gerhard-Herman, MD
* Diagnosis of DVT: April 2009
Slides
Video
* Peripheral Arterial Disease Update: March 2008
Slides
Samuel Z. Goldhaber, MD
* Anticoagulation Bridging: Hope or Hype: September 2008
Slides
* Anticoagulation Update: March 2008
Slides
* Championing Hospital Prophylaxis Strategies; Defining a Process; Creating a Team; Required Steps; Overcoming Barriers: April 2010
Summary
Slides
Video
* Optimal Duration of Anticoagulation for VTE: September 2010
Slides
Summary
* Pulmonary Embolism Update 2010: April 2010
Summary
Slides
Video
* Pulmonary Embolism Management: May 2010
Slides
* The Volunteer and Charitable: September 2009
Summary
Slides
Video
* Warfarin Genetics and Dosing: the New Pharmacogenomic Frontier: February 2007
Slides
Kendra Grant
* Patient Perspective: April 2009
Video
Jonathan Halperin, MD
* Atrial Fibrillation and Thrombosis: September 2009
Summary
Slides
Video
Job Harenberg, DVM
* Recommendations on Biosimilar LMWHs: July 2009
Video
Elliott R. Haut, MD, FACS
* Mandatory Computer-Based Decision Support System: April 2010
Summary
Slides
Video
Denise R. Hirsch, MD, FACC
* Update on the Prevention and Management of Venous Thromboembolism with Review of Current Guidelines: Spring 2009
Slides
Elaine Hylek, MD
* Implications of an Out-of-Range INR: Bleeding and Clotting Complications: February 2007
Slides
Craig M. Jackson, PhD
* Heparin & Low Molecular Weight Heparins: Safety of Heparin Biosimilars: Fall 2009
Slides
Audio
* Summary of United States Legislation and Proposed Bill: July 2009
Slides
Video
* BIOGENERIC LOW MOLECULAR WEIGHT HEPARINS: What are the differences and what difference do they make?
July 2009
Slides
Jovonne H. Jones, PharmD
* 7-Step Process to Walk Provider Through an Evidence-Based Medicine Risk Factor Assessment: April 2010
Summary
Slides
Video
Allen Kachalia, MD, JD
* Anticoagulation Management and Warfarin Safety: A Systems Approach: September 2008
Slides
Susan R. Kahn, MD
* Post Thrombotic Syndrome: September 2009
Summary
Slides
Video
Ajay K. Kakkar, MD
* Patient Advocacy and the British Parliament: February 2007
Slides
* The British Parliament: September 2007
Slides
Craig M. Kessler, MD
* Reversal of Hemorrhage: September 2007
Slides
* Cancer and Thrombosis: September 2009
Summary
Slides
Video
* Call to Action for the Protection of Patient Safety: July 2009
Slides
Video
* Follow-on Biologic Agents: Immunogenicity, Efficacy, and Safety: September 2010
Slides
Summary
* Hospital VTE Prevention Strategies for Cancer Patients: April 2010
Summary
Slides
Video
* Patient Safety and Generic Biologics: Winter 2010
* Thrombosis and Cancer: September 2008
Slides
Joshua Lee, MD
* VTE Prevention Protocol Across All Medical and Surgical Services: April 2010
Summary
Slides
Video
Peter Libby, MD
* Atherothrombosis: September 2009
Summary
Slides
Video
* Atherothrombosis and Plaque Rupture: July 2009
Summary
Slides
Video
* Vascular Biology of Venous Thrombosis: Janurary 2009
Slides
Video
JoAnn E. Manson, MD, DrPH
* Estrogen and Thrombosis: A Women’s Health Issue: September 2008
Slides
Peter W. Marks, MD, PhD
* Venous Thromboembolism: An Ounce of Prevention is Worth a Pound of Cure: Fall 2009
Slides
Sylvia McKean, MD
* Outpatient Treatment of VTE: February 2007
Slides
Jessica L. Mega, MD, MPH
* Antiplatelet Drugs in Acute Coronary Syndrome: April 2010
Summary
Slides
Video
Geno Merli, MD
* Patient Advocacy and the United States Congress: February 2007
Slides
* The United States Congress: September 2007
Slides
Rita M. Morrison, RN
* Patient Education and Patient Compliance: March 2008
Slides
Thomas J. Ortel, MD, PhD
* Anticoagulation Bridging: The NHBLI-Sponsored Trial: September 2009
Slides
Video
* Thrombophilia: September 2007
Michael J. Paidas, MD
* Recombinant Human Antithrombin: New Therapeutic Options: September 2009
Summary
Slides
Video
Sudha Parasuraman, MD
* Anticoagulation Armamentarium: Update on Drugs and Mechanisms: February 2007
Video
Gregory Piazza, MD
*Chronic Thromboembolic Pulmonary Hypertension: September 2010
Summary
* Physician Alerts to Prevent VTE: September 2009
Summary
Slides
Video
* Physician Alerts to Prevent Venous Thromboemoblism: April 2010
Summary
Slides
Video
Charles N. Pozner, MD
* Cardiac Arrest: An Emergency Response: April 2010
Slides
Video
Wolfram Raake, DVM
* European Perspective on Biosimilars and Follow-on Biologics: July 2009
Slides
Video
Frederic S. Resnic, MD, MSc
* Cardiac Catheterization and Catheter Embolectomy: Janurary 2009
Slides
Video
*
Coronary Stent Thrombosis : March 2008
Paul M. Ridker, MD
* Genetics and Cardiovascular Thrombosis : September 2007
Slides
* Update on the JUPITER Trial: September 2009
Slides
Video
* Update on JUPITER` Trial: April 2009
Slides
Video
Cathy G. Rosenfield, MD
* VTE in Children and Adolescents: September 2009
Summary
Slides
Video
Frank J. Rybicki, MD, PhD
* Diagnosis of Venous Thromboembolism: Janurary 2009
Slides
Video
Julio Sandoval, MD
* Pulmonary Hypertension: September 2009
Summary
Slides
Video
Arthur A. Sasahara, MD
* History of Venous Thrombosis: Janurary 2009
Slides
Video
* Panel Discussion: Advocacy Issues: April 2010
Video
Susan B. Shurin, MD (Deputy Director, NHLBI)
* The National Heart, Lung and Blood Institute : September 2008
Slides
Farzaneh A. Sorond, MD, PhD
* Stroke Update: March 2008
* Stroke Update: April 2009
Paul D. Stein, MD
* PE Diagnosis: March 2008
Slides
Michael B. Streiff, MD
* Mandatory Computer-Based Decision Support System: April 2010
Summary
Slides
Video
Thomas Sullivan, BSN
* Cardiopulmonary Resuscitation: April 2009
Slides
Video
Suresh Vedantham, MD
* Controversies Surrounding the Optimal Therapy of Extensive Leg DVT: September 2008
Slides
Jeanine M. Walenga, PhD
* Heparin Formulations: New Standards of Units: April 2010
Summary
Slides
Video
* Heparin Induced Thrombocytopenia: September 2007
* Heparin-Induced Thrombocytopenia: Controversies and Updates: September 2008
Slides
* Heparin & Low Molecular Weight Heparins: Safety of Heparin Biosimilars: Fall 2009
Jeffrey I. Weitz, MD
* New Antithrombotic Agents: September 2007
Slides
* Novel Oral Anticoagulants: September 2010
Slides
Summary
Andrew Whelton, MD
* Current Issues and Statements Surrounding Biosimilars and Follow-on Biologics: July 2009
Neil A. Zakai, MD
* Venous Thrombosis Risk in Medical Inpatients: Spring 2009
Slides
